AJP - Endo Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 282: E891-E898, 2002. First published December 18, 2001; doi:10.1152/ajpendo.00353.2001
0193-1849/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/4/E891    most recent
00353.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (38)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Preisler-Mashek, M. T.
Right arrow Articles by Alarid, E. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Preisler-Mashek, M. T.
Right arrow Articles by Alarid, E. T.
Vol. 282, Issue 4, E891-E898, April 2002

Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-alpha

Mara T. Preisler-Mashek, Natalia Solodin, Bethany L. Stark, Michael K. Tyriver, and Elaine T. Alarid

Department of Physiology, University of Wisconsin-Madison, Madison, Wisconsin 53706

Proteasome-mediated proteolysis modulates the cellular concentration of estrogen receptor-alpha (ERalpha ) and is induced by treatment of cells with 17beta -estradiol. Herein, we show that multiple receptor agonists, including 17alpha -estradiol and estriol as well as the antagonist ICI-182780, stimulate proteasome-dependent proteolysis of ERalpha in a process that requires ligand binding to the receptor. Proteolysis of receptor depends on ligand concentration, and there exists a direct correlation between ligand-binding affinity and the half-maximal dose of ligand required to stimulate receptor degradation. Furthermore, introduction of a point mutation into the receptor ligand-binding pocket yields a stable receptor resistant to proteolysis. Interestingly, although all ligands stimulate receptor degradation, the extent to which overall ER levels are affected varies with each ligand and is not related to ligand-binding affinity or activation of transcription. These results demonstrate ligand-specific regulation of ERalpha proteolysis, and they introduce the concept that cellular receptor concentration is governed not only at the level of induction of proteolysis but also by the efficiency with which the receptor is degraded.

steroid; nuclear receptor; antagonist; estriol; pituitary


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
G. Giamas, L. Castellano, Q. Feng, U. Knippschild, J. Jacob, R. S. Thomas, R. C. Coombes, C. L. Smith, L. R. Jiao, and J. Stebbing
CK1{delta} modulates the transcriptional activity of ER{alpha} via AIB1 in an estrogen-dependent manner and regulates ER{alpha}-AIB1 interactions
Nucleic Acids Res., May 1, 2009; 37(9): 3110 - 3123.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
C. C Valley, N. M Solodin, G. L Powers, S. J Ellison, and E. T Alarid
Temporal variation in estrogen receptor-{alpha} protein turnover in the presence of estrogen
J. Mol. Endocrinol., January 1, 2008; 40(1): 23 - 34.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
R. S. Bhattacharyya, A. V. Krishnan, S. Swami, and D. Feldman
Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells.
Mol. Cancer Ther., June 1, 2006; 5(6): 1539 - 1549.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
C. C. Valley, R. Metivier, N. M. Solodin, A. M. Fowler, M. T. Mashek, L. Hill, and E. T. Alarid
Differential Regulation of Estrogen-Inducible Proteolysis and Transcription by the Estrogen Receptor {alpha} N Terminus
Mol. Cell. Biol., July 1, 2005; 25(13): 5417 - 5428.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
Y.-S. Zhu, L.-Q. Cai, Y. Huang, J. Fish, L. Wang, Z.-K. Zhang, and J. L. Imperato-McGinley
Receptor Isoform and Ligand-Specific Modulation of Dihydrotestosterone-Induced Prostate Specific Antigen Gene Expression and Prostate Tumor Cell Growth by Estrogens
J Androl, July 1, 2005; 26(4): 500 - 508.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
R. R. Magness, T. M. Phernetton, T. C. Gibson, and D.-b. Chen
Uterine blood flow responses to ICI 182 780 in ovariectomized oestradiol-17{beta}-treated, intact follicular and pregnant sheep
J. Physiol., May 15, 2005; 565(1): 71 - 83.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
C. A Oliveira, G. A B Mahecha, K. Carnes, G. S Prins, P. T K Saunders, L. R Franca, and R. A Hess
Differential hormonal regulation of estrogen receptors ER{alpha} and ER{beta} and androgen receptor expression in rat efferent ductules
Reproduction, July 1, 2004; 128(1): 73 - 86.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. J. Pinzone, H. Stevenson, J. S. Strobl, and P. E. Berg
Molecular and Cellular Determinants of Estrogen Receptor {alpha} Expression
Mol. Cell. Biol., June 1, 2004; 24(11): 4605 - 4612.
[Full Text] [PDF]

Home page
 FASEB J.Home page
A. M. FOWLER, N. SOLODIN, M. T. PREISLER-MASHEK, P. ZHANG, A. V. LEE, and E. T. ALARID
Increases in estrogen receptor-{alpha} concentration in breast cancer cells promote serine 118/104/106-independent AF-1 transactivation and growth in the absence of estrogen
FASEB J, January 1, 2004; 18(1): 81 - 93.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online